Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer

BACKGROUND: More than three-quarters of primary breast cancers are positive for estrogen receptor alpha (ER; encoded by the gene ESR1), the most important factor for directing anti-estrogenic endocrine therapy (ET). Recently, mutations in ESR1 were identified as acquired mechanisms of resistance to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JNCI Cancer Spectr
Main Authors: Dahlgren, Malin, George, Anthony M, Brueffer, Christian, Gladchuk, Sergii, Chen, Yilun, Vallon-Christersson, Johan, Hegardt, Cecilia, Häkkinen, Jari, Rydén, Lisa, Malmberg, Martin, Larsson, Christer, Gruvberger-Saal, Sofia K, Ehinger, Anna, Loman, Niklas, Borg, Åke, Saal, Lao H
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8060794/
https://ncbi.nlm.nih.gov/pubmed/33937624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkab028
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki